Industry Advisory Board

The Industry Advisory Board (IAB) provides strategic guidance, shapes research priorities, and ensures the BRAIN Center's work remains aligned with real-world industry needs and opportunities.

Stanley Chang

IAB Chair

Stanley Chang

BRAIN I/U CRC IAB Chair, President and Chief Product Officer, Scialiva

Stanley brings a distinctive blend of biotechnology, high-tech, and legal expertise. As an executive, entrepreneur, investor, and co-founder in biotech and high-tech ventures, he managed business operations and P&L responsibilities while strategically integrating diverse disciplines while driving innovation. Stanley has hands-on experience in areas critical to the IUCRC-BRAIN mission, including diagnostic tests, AI-driven algorithms, encryption, and error correction systems. Additionally, his legal background as an attorney specializing in intellectual property and transactional matters positions him to navigate complex industry-academic collaborations.

Craig Mermel

IAB Co-Chair

Craig Mermel

BRAIN I/U CRC IAB Co-Chair, MD, PhD, President and Chief Product Officer, Precision Neuroscience

"Everyone deserves an unrestricted life. Restoring freedom through brain-computer interfaces, AI, smart exoskeletons, and other neuroengineering innovations can help provide breakthrough treatments to people with neurological conditions. At the IUCRC BRAIN – a leading industry-university-government partnership – industry members collaborate with world class researchers at premier institutions worldwide to advance the state of the art in neurotechnology.

A modest investment into BRAIN membership gives industry members the leverage and big returns that would not be possible otherwise. We get to work side by side with billion-dollar neurotech firms, interact with federal regulatory agencies, hire highly skilled students, have a say in selecting cutting edge projects, have the choice to commercialize novel devices and be a part of the neurotechnology revolution: Neuroengineered for What's is Next."